You are here

Article Text

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. SLE, Sjögren's and APS - clinical aspects (other than treatment)
FRI0431 Venous and Arterial Thrombosis in Sle: Differences in Natural History
  1. K. Hickman1,
  2. L. Magder2,
  3. M. Petri3
  1. 1University College London Medical School, London, United Kingdom
  2. 2Epidemiology & Public Health, University of Maryland School of Medicine
  3. 3Division of Rheumatology, Johns Hopkins University, Baltimore, United States

Abstract

Background Thrombosis is increased in SLE due to disease activity and co-morbid factors including antiphospholipid antibodies. We separately investigated the natural history of venous vs. arterial thrombosis.

Methods 2250 patients were enrolled in a prospective cohort; 334 had a thrombotic event before cohort entry or diagnosis of SLE. For ALL thrombosis, age over 60 yrs, male gender, African-American ethnicity, SLEDAI greater than 3, and prednisone greater than 0 were risk factors. In general, rates of venous thrombosis were fairly constant, while rates of arterial thrombosis increased with age.

Results See Table 1.

View this table:
Table 1.

Incidence rates (per 1000 patient-years) of thrombosis

Conclusions Prevention of venous thrombosis remains important throughout the course of SLE. Prevention of arterial thrombosis becomes more important later in the disease course. Disease activity is more of a risk factor for arterial thrombosis while prednisone is a risk factor for both venous and arterial thrombosis.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.3776

https://doi.org/10.1136/annrheumdis-2014-eular.3776

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.